DRACHMAN JONATHAN G

CIK 00015884674 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001588467

Recent Transactions

17 trades

Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−1,016→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−5,415→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−5,531→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,300→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-03-08+415→ 5,415 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-27+5,000→ 5,000 total
Award
Calithera Biosciences, Inc.
Stock Option (Right to Buy)
2020-06-09+20,000→ 20,000 total
Award
Neurogene Inc.$NGNE
Series A Preferred Stock
2019-08-08+12,616→ 12,616 total
Award
Neurogene Inc.$NGNE
Common Stock
2019-08-08+568,039→ 568,039 total
Exercise/Conversion
Seagen Inc.
Incentive Stock Option (right to buy)
2017-01-25−5,000→ 0 total
Exercise/Conversion
Seagen Inc.
Common Stock
2017-01-25$10.29/sh+5,000→ 114,837 total
Exercise/Conversion
Seagen Inc.
Common Stock
2016-06-02$10.29/sh+5,000→ 88,246 total
Exercise/Conversion
Seagen Inc.
Incentive Stock Option (right to buy)
2016-06-02−5,000→ 5,000 total
Award
Seagen Inc.
Incentive Stock Option (right to buy)
2015-08-25+2,554→ 2,554 total
Award
Seagen Inc.
Common Stock
2015-08-25+20,000→ 82,724 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2015-08-25+47,446→ 47,446 total
Sale
Seagen Inc.
Common Stock
2015-08-20$42.02/sh−4,462→ 62,724 total

Companies

Recent Filings

Address

C/O HARPOON THERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov